Nordic Bioscience A/S
🏢 View company profile →18Patents
18Active
18Granted
46Portfolio score
Filing activity: Nov 3, 2006 → Jan 26, 2022 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9206464B2 | Fibrosis biomarker assay | Physics | 7 | Active |
| US9733260B2 | Biochemical markers for neurodegenerative conditions | Physics | 5 | Active |
| US9500659B2 | In vitro assessment of cardiovascular events by assay for neo-eptitopes of titin protein | Physics | 3 | Active |
| US9359633B2 | Biochemical markers for CVD risk assessment | Physics | 3 | Active |
| US9404932B2 | Pathology biomarker assay | Physics | 3 | Active |
| US9606130B2 | Fibrosis biomarker assay | Physics | 3 | Active |
| US9459260B2 | Detection of diagnostic peptides | Physics | 2 | Active |
| US9880177B2 | Fibrosis biomarker assay | Physics | 1 | Active |
| US9891234B2 | Biochemical markers for CVD risk assessment | Physics | 1 | Active |
| US10001490B2 | Biochemical markers for pulmonary and other diseases | Physics | 0 | Active |
| US10267809B2 | Biochemical markers for CVD risk assessment | Physics | 0 | Active |
| US11634479B2 | Immunoassay for collagen type VI | Physics | 0 | Active |
| US12366582B2 | Collagen type X alpha-1 assay | Physics | 0 | Active |
| US8835389B2 | Use of calcitonin for the treatment of RA | Human Necessities | 0 | Active |
| US11531028B2 | Collagen type X alpha-1 assay | Physics | 0 | Active |
| US9726674B2 | PIIINP neo-epitope assay | Physics | 0 | Active |
| US9835631B2 | Combined biomarker measurement of fibrosis | Physics | 0 | Active |
| US12391747B2 | Type XXIII collagen assay | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.